NSE filing, NSE: ASCOM. Summary written from the filing by ALFA Finder's alert engine.
Ascom Leasing & Investments Ltd: key numbers
- Share price
- ₹187.45
- Market cap
- ₹219.6 Cr
- Revenue (annual)
- ₹13.06 Cr
- Net profit (annual)
- ₹5.23 Cr
- P/E (TTM)
- 42.0×Sector 19.7×
- Promoter holding
- 74.85%
- FII holding
- 0.00%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Ascom Leasing & Investments Ltd
All →Ascom Leasing & Investments Other Announcement
Ascom Leasing filed its Reconciliation of Share Capital Audit Report for the quarter ended September 30, 2026, as required under SEBI regulations.
Ascom Leasing & Investments Annual General Meeting
Ascom Leasing & Investments Limited held its 39th Annual General Meeting on September 30, 2026. Members approved the annual financial statements and various appointments.
Ascom Leasing & Investments Dividend
Ascom Leasing & Investments Limited fixed September 18, 2026, as the record date for its ₹0.25 per share final dividend.
Ascom Leasing & Investments Management Change
Ascom Leasing & Investments Limited has appointed M/s. Anuj Gupta & Associates as the Secretarial Auditor of the company.
Ascom Leasing & Investments Annual General Meeting
Ascom Leasing & Investments Limited has filed its Annual Report for the financial year 2025-26, including the notice for its 39th Annual General Meeting.
Ascom Leasing & Investments Board Meeting Outcome
Ascom Leasing announced its board meeting outcome, recommending a final dividend of ₹0.25 per share and approving various director appointments and the upcoming 39th AGM.
Other board meeting date announcements
All →Patel Engineering Board Meeting Date
Patel Engineering has scheduled its Board meeting for November 5, 2026, to approve Q1 and H1 FY27 unaudited results. No financial figures or decisions are reported in this advance notice.
GKB Ophthalmics Board Meeting Date
GKB Ophthalmics scheduled its Board Meeting for November 12, 2026. The meeting will consider approving unaudited results for the September 30, 2026 quarter and half year.
Bombay Oxygen Investments Board Meeting Date
Board meeting scheduled for Nov 6, 2026 to approve Q1 and H1 FY27 unaudited results. Trading window closed for insiders Oct 1–Nov 8, 2026.
OCCL Board Meeting Date
OCCL Ltd has scheduled its Board meeting for 6 November 2026 to consider Q1 FY27 unaudited results and a possible interim dividend. The trading window for designated persons closed from 1 October 2026.
TCM Board Meeting Date
TCM Limited intimated a Board meeting for 06/11/2026 to approve Q2 FY27 results. The trading window will reopen 48 hours after the results declaration.
Mercury Laboratories Board Meeting Date
Mercury Laboratories scheduled its Board meeting for November 5, 2026, to approve Q2/H1 FY27 results. Trading window remains closed until 48 hours post-announcement.